DNA Testing Market Report 2026

DNA Testing Market Overview

• DNA Testing market size has reached to $20.04 billion in 2025 • Expected to grow to $32.71 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Increasing Prevalence Of Genetic Disorders Fuels Growth In Genetic Testing Services Market • Market Trend: Advancements In Precancer Detection DNA Tests • North America was the largest region in 2025.

What Is Covered Under DNA Testing Market?

Deoxyribonucleic acid (DNA) testing refers to the process of analyzing an individual's DNA, that carries the instructions for an organism's development, functioning, and traits. It involves extracting DNA from cells, typically obtained from bodily fluids or tissues like blood, saliva, or hair, and then examining specific regions or sequences of the DNA molecule. The main product types of DNA testing are equipment, consumables, and software and services. Equipment refers to the various instruments, devices, and tools used in the processes involved in analyzing DNA samples. Various technologies are used in this testing, such as polymerase chain reaction (PCR)-based, in-situ hybridization, microarray, and next-generation sequencing (NGS) DNA diagnosis, and they are used in various applications, including newborn DNA screening, pre-natal DNA carrier screening, oncology diagnostics and histopathology, pre-implantation diagnosis, infectious disease diagnostics, pharmacogenomics diagnostic testing, identify diagnostics and forensics, and others.

What Is The DNA Testing Market Growth Forecast?

The dna testing market size is expected to see strong growth in the next few years. It will grow to $32.71 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to precision medicine integration, ai-based genetic interpretation, population screening programs, clinical genomics expansion, regulatory support for molecular diagnostics. Major trends in the forecast period include expansion of dna testing in clinical diagnostics, growing use in prenatal and newborn screening, rising adoption in oncology and pharmacogenomics, integration of automated testing platforms, increased demand for personalized genetic insights.

Global DNA Testing Market Segmentation

1) By Product Type: Equipment, Consumables, Software And Services 2) By Technology: Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis 3) By Application: Newborn DNA Screening, Pre-Natal DNA Carrier Screening, Oncology Diagnostics And Histopathology, Pre-implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics And Forensic, Other Applications Subsegments: 1) By Equipment: PCR (Polymerase Chain Reaction) Machines, Sequencing Instruments, Microarray Systems, Electrophoresis Equipment 2) By Consumables: PCR Reagents, Sequencing Reagents, Hybridization Reagents, Enzymes And Buffers 3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Services, Consulting And Technical Support

What Is The Driver Of The DNA Testing Market?

The increasing prevalence of genetic disorders is expected to propel the growth of the DNA testing market going forward. Genetic disorders are medical conditions caused by abnormalities in an individual's DNA that lead to physical, developmental, or functional impairments. The rising prevalence of genetic disorders is driven by expanded genetic screening, improved diagnostic capabilities, increased public awareness, and the continued occurrence of consanguineous marriages in certain populations. DNA testing market supports this need by enabling early and accurate diagnosis, prognosis assessment, personalized treatment planning, and informed family-planning decisions based on an individual’s genetic profile. For instance, in February 2023, according to the World Health Organization (WHO), congenital diseases caused an estimated 240,000 newborn deaths globally within the first 28 days of life each year, and according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome annually in the United States, representing 1 in every 700 births. Therefore, the increasing prevalence of genetic disorders is driving the growth of the DNA testing industry.

Key Players In The Global DNA Testing Market

Major companies operating in the dna testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics

Global DNA Testing Market Trends and Insights

Major companies operating in the DNA testing market are focusing on developing advanced testing solutions such as precancer detection DNA tests to improve early diagnosis, enable timely intervention, and enhance patient outcomes in cancer care. Precancer detection DNA tests refer to molecular diagnostic assays that identify early genetic or epigenetic alterations such as mutations or methylation patterns associated with the initial stages of cancer development, allowing clinicians to detect disease before symptoms arise. For instance, in November 2023, Lucid Diagnostics Inc., a US-based esophageal cancer prevention diagnostics company, launched EsoGuard 2.0, a next-generation esophageal DNA test that offers improved assay performance and reduced costs through enhanced molecular techniques and higher DNA yield. Using the EsoCheck Cell Collection Device, the test analyzes esophageal cell DNA through bisulfite conversion, PCR amplification, and next-generation sequencing to detect gene-specific methylation changes associated with esophageal precancer and cancer, providing clinicians with a powerful tool for early detection and cancer prevention.

What Are Latest Mergers And Acquisitions In The DNA Testing Market?

In January 2023, QIAGEN N.V., a Netherlands-based biotechnology company, acquired Verogen Inc. for $150 million. Through this acquisition, QIAGEN aims to strengthen its leadership in the human identification and forensics market by integrating Verogen’s next-generation sequencing tools and services to support global criminal and missing-persons investigations. Verogen Inc. is a US-based forensic genomics company that provides DNA testing tools, specializing in next-generation sequencing technologies for human identification and forensic analysis.

Regional Outlook

North America was the largest region in the DNA testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the DNA Testing Market?

The DNA testing market consists of revenues earned by entities by providing services such as paternity testing, maternity testing, genetic health risk assessment, carrier screening, pharmacogenomics testing, forensic DNA analysis, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA testing market also includes sales of sterile swabs, DNA collection kits, thermal cyclers, DNA sequencers, microarray platforms, DNA extraction kits, polymerase chain reaction (PCR) reagents, and microscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the DNA Testing Market Report 2026?

The dna testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dna testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.